×

UPDATED – 2022 Safety Protocols

CHI has instituted mandatory health and safety protocols for all in-person participants. We are excited to bring our community back together in 2022, with trust and safety as our top priorities. All in-person participants are required to:

  • Provide proof of full vaccination against COVID-19. You will be asked to present your vaccination card (or a photo of it) at registration.

Conference Programs

POCT and Infectious Disease Stream
Enabling Point-of-Care Diagnostics
Advanced Diagnostics for Infectious Disease
Early Detection and Liquid Biopsy Stream
Liquid Biopsy for Disease Management
Early Cancer Surveillance

2022 PLENARY PANEL DISCUSSIONS

Legislative Efforts to Modernize Diagnostic Oversight

Cynthia A. Bens

MODERATOR:
Cynthia A. Bens
Senior Vice President, Public Policy, Personalized Medicine Coalition

Jeff Allen, PhD

Jeff Allen, PhD
Executive Director, Friends of Cancer Research

Sarah Thibault-Sennett, PhD

Sarah Thibault-Sennett, PhD
Director, Public Policy & Advocacy, Association for Molecular Pathology

Lauren R. Silvis, PhD

Lauren R. Silvis, PhD
Senior Vice President, External Affairs, Tempus, Inc.

Thomas Sparkman, JD

Thomas Sparkman, JD
Senior Vice President, Government Affairs and Policy, American Clinical Laboratory Association

Andrew C. Fish, PhD

Andrew C. Fish, PhD
Executive Director & Head, Center for Digital Health, AdvaMed

,

Self-Testing: What We Have Learned from the Pandemic for Future Applications

Franklin R. Cockerill III, MD

MODERATOR:
Franklin R. Cockerill III, MD
Founding Partner, Trusted Health Advisors; Adjunct Professor, Medicine, Rush University

Karen A. Heichman, PhD

Karen A. Heichman, PhD
Deputy Director, Bill & Melinda Gates Foundation

Jack Jeng, MD, MBA

Jack Jeng, MD, MBA
Director, Medical Affairs, BD

Elizabeth M. Marlowe, PhD

Elizabeth M. Marlowe, PhD, D(ABMM)
Senior Scientific Director, Head R&D Infectious Diseases & Immunology, Quest Diagnostics Nichols Institute

Donna M. Wolk, PhD

Donna M. Wolk, PhD
Chief, Molecular & Microbial Diagnostics & Development, Geisinger Health System

Nicole Zitterkopf, PhD

Nicole Zitterkopf, PhD, D(ABMM), MPH, MT(ASCP)
Vice President Laboratory, Service Line Advancement Team, OptumHealth

Select an In-person or virtual option, and you have the flexibility to switch your preferred event experience at any time leading up to the conference. Our flexible registration is designed to take the uncertainties out of these uncertain times

Welcome to the 2022 Next Generation Dx Summit

Advancing Diagnostics Together

We are proud to host Cambridge Healthtech Institute's Fourteenth Annual Next Generation Dx Summit which will take place in-person at the Grand Hyatt Washington, D.C. on August 22-24. The Next Generation Dx Summit is the nexus for key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation. The event provides a valuable window on how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care. Now in its fourteenth year, the Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important topics for the industry.

Benefits of attending include:

  • Form partnerships with major players in the evolving areas of diagnostics
  • Gain a comprehensive, up-to-date view of diagnostics, including the latest rapid and molecular diagnostics for COVID-19
  • Gather important industry announcements
  • Hear late-breaking news on lessons learned from COVID-19 testing
  • Review innovative products and novel platforms and technologies in the exhibit hall and the poster session


Thank You to Our 2022 Premier Sponsors

View all sponsors


Testimonial


Join the Community at Next Generation Dx Summit

Conference Programs

Final Agenda Now Available

VIEW AGENDA

Sponsor & Exhibit Opportunities

View Prospectus & Attendee Breakdown

VIEW DETAILS

Conference Attendance

Register Early for Maximum Savings

REGISTER NOW

Press Participation

Hear Industry Updates Straight from Diagnostics Innovators

LEARN MORE